Metabolome biomarkers for conversion to multiple sclerosis in patients with clinically isolated syndrome

被引：0
|
作者：
Gasperi, C. [1 ]
Schafferer, S. [2 ]
Hoshi, M-M. [1 ]
Hemmer, B. [1 ,3 ]
Berthele, A. [1 ]
机构：
[1] Tech Univ Munich, Dept Neurol, Munich, Germany
[2] BIOCRATES Life Sci AG, Innsbruck, Austria
[3] Munich Cluster Syst Neurol SyNergy, Munich, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P857
引用
收藏
页码：455 / 455
页数：1
相关论文
共 50 条
  • [41] Characteristics of a French prospective cohort of 233 clinically isolated syndrome patients and predictive factors of conversion to multiple sclerosis
    Thouvenot, E.
    Audry-Chaboud, D.
    Castelnovo, G.
    Benrabah, R.
    Lemaire, N.
    Salin, B.
    Coustans, M.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 369 - 369
  • [42] Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome
    Miclea, A.
    Salmen, A.
    Wiest, R.
    Wagner, F.
    Hoepner, A.
    Schrewe, L.
    Zoehner, G. -C.
    Kamber, N.
    Chan, A.
    Hoepner, R.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 530 - 530
  • [43] Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis
    Fiorini, Michele
    Zanusso, Gianluigi
    Benedetti, Maria Donata
    Righetti, Pier Giorgio
    Monaco, Salvatore
    PROTEOMICS CLINICAL APPLICATIONS, 2007, 1 (09) : 963 - 971
  • [44] Cerebrospinal fluid biomarkers dissect extreme phenotypes of clinically isolated syndrome and early multiple sclerosis
    Luessi, F.
    Engel, S.
    Steffen, F.
    Friedrich, M.
    Spreer, A.
    Poplawski, A.
    Bittner, S.
    Zipp, F.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 244 - 244
  • [45] MRI indices as predictors of clinically definite multiple sclerosis development in patients with a clinically isolated syndrome
    Myalovitska, O.
    Nour, S. Sepehri
    Lobanova, I.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 168 - 168
  • [46] Clinically isolated syndrome and multiple sclerosis: Rethinking the arsenal
    Krupa Pandey
    Fred D. Lublin
    Current Treatment Options in Neurology, 2009, 11 : 193 - 202
  • [47] Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
    Metz, L. M.
    Li, D. K. B.
    Traboulsee, A. L.
    Duquette, P.
    Eliasziw, M.
    Cerchiaro, G.
    Greenfield, J.
    Riddehough, A.
    Yeung, M.
    Kremenchutzky, M.
    Vorobeychik, G.
    Freedman, M. S.
    Bhan, V.
    Blevins, G.
    Marriott, J. J.
    Grand'Maison, F.
    Lee, L.
    Thibault, M.
    Hill, M. D.
    Yong, V. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (22): : 2122 - 2133
  • [48] Clinically isolated syndrome and multiple sclerosis: Rethinking the arsenal
    Pandey, Krupa
    Lublin, Fred D.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2009, 11 (03) : 193 - 202
  • [49] Mood and coping in clinically isolated syndrome and multiple sclerosis
    Bianchi, V.
    De Giglio, L.
    Prosperini, L.
    Mancinelli, C.
    De Angelis, F.
    Barletta, V.
    Pozzilli, C.
    ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 (06): : 374 - 381
  • [50] Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis
    Benedetti, Maria Donata
    Filippini, Graziella
    Solari, Alessandra
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (08): : 788 - 789
12345